Preparation and in vitro evaluation of mebeverine HCl colon-targeted drug delivery system

Pharmaceutical Development and Technology

Volumn 16, Issue 4, 2011, Pages 331-342

  Abdullah, Ghassan Z ^a   Abdulkarim, Muthanna F ^a   Chitneni, Mallikarjun ^a   Mutee, Ahmed F ^a   Ameer, Omar Z ^a   Salman, Ibrahim M ^a   Noor, Azmin M ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Colon targeting; Eudragit; Mebeverine Hcl; Pectin

Indexed keywords

ALGINIC ACID; CELLACEFATE; ETHYL CELLULOSE; EUDRAGIT; MAGNESIUM STEARATE; MEBEVERINE; PECTIN; PHOSPHATE BUFFERED SALINE;

ARTICLE; COLON; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG SYNTHESIS; DRUG TARGETING; ENTERIC COATED TABLET; IN VITRO STUDY; MATRIX TABLET; PRIORITY JOURNAL; SLOW DRUG RELEASE; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS;

ALGINATES; CELLULOSE; COLON; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYDROGEN-ION CONCENTRATION; PARASYMPATHOLYTICS; PECTINS; PHENETHYLAMINES; POLYMETHACRYLIC ACIDS; SOLUBILITY; TABLETS, ENTERIC-COATED;

EID: 79960270062     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837451003739255     Document Type: Article

References (48)

1. Nykänen P, Lempää S, Aaltonen ML, Jũrjenson H, Veski P, Morvola M. Citric acid as excipient in multiple-unit enteric-coated tablets for targeting drugs on the colon. Int J Pharm 2001;229:155-162. (Pubitemid 32972090)
2. Minko T. Drug targeting to the colon with lectins and neoglycoconjugates. Adv Drug Deliv Rev 2003;56:491-509.
3. Fukui E, Miyamura N, Uemura K, Kobayashi M. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. Int J Pharm 2000;204:7-15.
4. Liu L, Fishman ML, Kost J, Hicks KB. Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials 2003;24:3333-3343. (Pubitemid 36581891)
5. Yang L, Chu JS, Fix JA. Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharm 2002;235:1-15. (Pubitemid 34185432)
6. Pitarresi G, Casadei MA, Mandracchia D, Paolicelli P, Palumbo FS, Giammona G. Photo-cross linking of dextran and polyaspartamide derivatives: A combination suitable for colon-specific drug delivery. J Control Release 2007;119:328-338. (Pubitemid 46770878)
7. Yang L, James S, Chu and Joseph AF. Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharm 2002;235:1-15. (Pubitemid 34185432)
8. Marvola M, Nykäanen P, Rautio S, Isonen N, Autere AM. Enteric polymers as binders and coating materials in multiple-unit sitespecific drug delivery systems. Eur J Pharm 1999;7:259-267. (Pubitemid 29015744)
9. Azarmi S, Farid J, Nokhodchi A, Bahari-Saravi SM, Valizadeh H. Thermal treating as a tool for sustained release of Indomethacin from Eudragit RS and RL matrices. Int J Pharm 2002;246:171-177. (Pubitemid 35247989)
10. Vergnaud JM. Controlled drug release from oral dosage forms. London: Ellis Harwood Limited; 1993.
11. Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. Philadelphia: Lea and Febiger; 1986.
12. Rey H, Wagner KG, Wehrlé P, Schmidt PC. Development of matrix-based theophylline sustained-release micro tablets. Drug Dev Ind Pharm 2000;26:21-26. (Pubitemid 30075298)
13. Eudragit RL and RS data sheets. Darmstadt: Röhm Pharma GmbH: 1991
14. Pignatello R, Ferro M, Guidi GD, Salemi G, Vandelli MA, Guccione S, Geppi M, Forte C, Puglisi G. Preparation, characterization and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100R and RL100R. Int J Pharm 2001;218:27-42. (Pubitemid 32406154)
15. Omari DM, Sallam A, Abd-Elbary A, El-Samaligy M. Lactic acidinduced modifications in films of Eudragit RL and RS aqueous dispersions. Int J Pharm 2004;274:85-96. (Pubitemid 38457009)
16. Eudragit L and S data sheets. Darmstadt: Röhm Pharma GmbH: 1991.
17. Moustafine RI, Kemenova VA, Mooter GV. Characteristics of inter polyelectrolyte complexes of Eudragit E 100 with sodium alginate. Int J Pharm 2005;294:113-120. (Pubitemid 40462326)
18. Moustafine RI, Zaharov IM, Kemenova VA. Physicochemical characterization and drug release properties of EudragitR E PO/ EudragitR L 100-55 inter-polyelectrolyte complexes. Eur J Pharm Biopharm 2006;63:26-36.
19. Moustafine RI, Margulis EB, Sibgatullina LF, Kemenova VA, Mooter GV. Comparative evaluation of inter-polyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55as potential carriers for oral controlled drug delivery. Eur J Pharm Biopharm 2008;70:215-225.
20. Sriamornsak P, Sungthongjeen S. Modification of theophylline release with alginate gel formed in hard capsules. AAPS PharmSciTech.2007;8(3)Article 51.
21. Toti US, Aminabhavi TM. Different viscosity grade sodium alginate and modified sodium alginate membranes in pervaporation separation of water + acetic acid and water + isopropanol mixtures. J Membr Sci 2004;228:199-208. (Pubitemid 38064372)
22. Gao C, Liu M, Chen J, Zhang X. Preparation and controlled degradation of oxidized sodium alginate hydrogel. Polym Degrad Stabil 2009;94:1405-1410.
23. Kenyon DA, Lerner CJ, Landau EI, Strauss I, Caron E, Penhasi D, Rubinstein A, Wilding IR. The use of scintigraphy to provide proof of concept for novel polysaccharide preparations designed for colonic drug delivery. Pharm Res 1997;14:103-107. (Pubitemid 27113323)
24. Semdé R, Amighi K, Devleeschouwer MJ, Moes AJ. Studies of pectin HM: EudragitR RL: EudragitR NE film-coating formulations intended for colonic drug delivery. Int J Pharm 2000;197:181-192. (Pubitemid 30125789)
25. Li D, McHugh MA. Solubility behavior of ethyl cellulose in supercritical fluid solvents. J Supercrit Fluids 2004;28:225-231.
26. Crowley MM, Schroeder B, Fredersdorf A, Obara S, Talarico M, Kucera S, McGinity JW. Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. Int J Pharm 2004;269:509-522. (Pubitemid 38045312)
27. Builders PF, Kunle OO, Okpaku LC, Builders MI, Attama AA, Adikwu MU. Preparation and evaluation of mucinated sodium alginate micro-particles for oral delivery of insulin. Eur J Pharm Biopharm 2008;70:777-783.
28. Haznedar S, Dortunc B. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm 2004;269:131-140. (Pubitemid 38032830)
29. Al-Taani BM, Tashtoush BM. Effect of microenvironment pH of swellable and erodible buffered matrices on the release characteristics of diclofenac sodium. AAPS Pharm Sci Tech 2003;4:article 43.
30. Brittain HG. Analytical profiles of drug substances and excipients. California: Elsevier Science; 2002.
31. DuspatalinR Retard 200 mg capsules, available worldwide from the website: /products/gastroentero/Duspatalin.
32. Sameh MA, Abdel-Hady SE, El-Shamy AA, El-Dessouky HF. Formulation of an antispasmodic drug as a topical local anesthetic. Int J Pharm 2006;326:107-118. (Pubitemid 44754911)
33. Omaimah MN. In vitro adsorption of mebeverine hydrochloride onto kaolin and its relationship to pharmacological effects of the drug in vivo. Pharmaceutica Acta Helvetiae 1997;72:11-21.
34. Dai N, Cong Y, Yuan H. Prevalence of irritable bowel syndrome among undergraduates in Southeast China. Digest Liver Dis 2008;40:418-424.
35. British Pharmacopoeia BP. London: British Pharmacopoeia Commission; 2004.
36. United States Pharmacopeia and United States Pharmacopeial Convention USP 27. Philadelphia: United States Pharmacopeial Convention; 2003.
37. Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm 2006;318:103-117. (Pubitemid 43963308)
38. Kuksal A, Tiwary AK, Jain NK, Jain S. Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS PharmSciTech 2006;7(1):Article 1.
39. Reddy KR, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation. AAPS Pharm Sci Tech 2003;4:Article 61.
40. Lopes CM, Lobo JMS, Pinto JF, Costa PC. Compressed matrix core tablet as a quick/slow dual-component delivery system containing Ibuprofen. AAPS Pharm Sci Tech 2007;8: Article 76.
41. Patrick JS. Martins physical pharmacy and pharmaceutical science chemical; physical chemical and biopharmaceutical principles in the pharmaceutical sciences. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
42. Pham AT, Lee PI. Probing the mechanism of drug release from hydroxyl propyl methyl cellulose matrices. Pharm Res 1994;11:1379-1384. (Pubitemid 24339641)
43. Yang LB, Fassihi R. Examination of drug solubility, polymer type, hydrodynamics and loading dose on drug release behavior from a triple-layer asymmetric configuration delivery system. Int J Pharm 1997;155:219-229. (Pubitemid 27380408)
44. Pather SI, Russell I., Syce JA, Neau SH. Sustained release theophylline tablets by direct compression. Part 1: Formulation and in vitro testing. Int J Pharm 1998;164:1-10. (Pubitemid 28160092)
45. Wakerly Z, Fell JT, Attwood D, Parkins DA. In vitro evaluation of pectin-based colonic drug delivery systems. Int J Pharm 1996;129:73-77. (Pubitemid 26097977)
46. Kubo W, Konno Y, Miyazaki S, Attwood D. In situ gelling pectin formulations for oral sustained delivery of paracetamol. Drug Dev Ind Pharm 2004;30:593-599. (Pubitemid 38924629)
47. Pornsak S, Sungthongjee S. Modification of theophylline release with alginate gel formed in hard capsules. AAPS Pharm Sci Tech 2007;8:Article 51.
48. Ellison T, Snyder A, Bolger J, Okun R. Metabolism of orphenadrine citrate in man. J Pharmacol Exp Ther 1971;176: 284-295.